Clinical Trial
New insights on SOM230, a universal somatostatin receptor ligand
Affiliations
- PMID: 15233205
Item in Clipboard
Clinical Trial
New insights on SOM230, a universal somatostatin receptor ligand
J Endocrinol Invest.
2003.
No abstract available
Similar articles
-
Distribution and functionality of the somatostatin receptor subtypes in acromegaly.J Endocrinol Invest. 2003;26(8 Suppl):4-7. J Endocrinol Invest. 2003. PMID: 15233203 Review. No abstract available.
-
The effects of somatostatin analogs on biochemical parameters in acromegaly.J Endocrinol Invest. 2003;26(8 Suppl):46-9. J Endocrinol Invest. 2003. PMID: 15233212 Review. No abstract available.
-
A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients.J Clin Endocrinol Metab. 2004 Feb;89(2):638-45. doi: 10.1210/jc.2003-031052. J Clin Endocrinol Metab. 2004. PMID: 14764775 Clinical Trial.
-
Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.Clin Pharmacol Ther. 2005 Jul;78(1):69-80. doi: 10.1016/j.clpt.2005.04.003. Clin Pharmacol Ther. 2005. PMID: 16003295 Clinical Trial.
-
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors.Expert Opin Investig Drugs. 2014 Dec;23(12):1619-35. doi: 10.1517/13543784.2014.942728. Epub 2014 Jul 25. Expert Opin Investig Drugs. 2014. PMID: 25060168 Review.
Cited by
-
Recent trends in the treatment of well-differentiated endocrine carcinoma of the small bowel.World J Gastroenterol. 2010 Apr 14;16(14):1696-706. doi: 10.3748/wjg.v16.i14.1696. World J Gastroenterol. 2010. PMID: 20380000 Free PMC article. Review.
-
Pharmacological treatments for thyroid eye disease.Drugs. 2006;66(13):1685-700. doi: 10.2165/00003495-200666130-00003. Drugs. 2006. PMID: 16978034 Review.
-
Currently available somatostatin analogs are not good for Graves' orbitopathy.J Endocrinol Invest. 2006 May;29(5):389-90. doi: 10.1007/BF03344119. J Endocrinol Invest. 2006. PMID: 16794359 No abstract available.
-
The Role of Somatostatin Analogues in the Control of Diarrhea and Flushing as Markers of Carcinoid Syndrome: A Systematic Review and Meta-Analysis.J Pers Med. 2023 Feb 9;13(2):304. doi: 10.3390/jpm13020304. J Pers Med. 2023. PMID: 36836538 Free PMC article. Review.
-
Medical suppression of hypercortisolemia in Cushing's syndrome with particular consideration of etomidate.Pituitary. 2012 Jun;15(2):117-25. doi: 10.1007/s11102-011-0314-3. Pituitary. 2012. PMID: 21556813 Review.